European Basic Pharmaceutical Products and Pharmaceutical Preparations Turnover Share by Country (Million Euros)

Based on the latest data, Germany and Switzerland dominate the European pharmaceutical market, with Germany holding a 24.6% share and Switzerland closely trailing at 24.31%. Belgium (10.06%) and France (9.76%) also hold significant portions of the market. Year-on-year variations reveal strong performance in Sweden (28.54%), Belgium (11.71%), and Cyprus (15.42%), while France and the United Kingdom saw minor declines. Over the past five years, consistent growth in key markets like Germany, Switzerland, and Belgium indicates a robust and expanding sector.

Future trends to watch include the increasing role of Sweden as a rapidly growing player, technological advancements driving turnover in smaller markets, and potential volatility in major markets due to regulatory changes and economic fluctuations. Additionally, continuous monitoring of emerging markets such as Cyprus, Romania, and Croatia could offer new growth opportunities.